1-6 of 6
Christian Brieghel
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Long-term follow-up of MRD-guided ibrutinib plus venetoclax in relapsed CLL: phase 2 VISION/HO141 trial

Open Access
Clinical Trials & Observations
Carsten U. Niemann, Julie Dubois, Kazem Nasserinejad, Caspar da Cunha-Bang, Sabina Kersting, Lisbeth Enggaard, Gerrit J. Veldhuis, Rogier Mous, Clemens H.M. Mellink, Anne-Marie F. van der Kevie-Kersemaekers, Johan A. Dobber, Christian B. Poulsen, Wida Razawy, René Hollestein, Henrik Frederiksen, Ann Janssens, Ida Schjødt, Ellen C. Dompeling, Juha Ranti, Christian Brieghel, Mattias Mattsson, Mar Bellido, Hoa T. T. Tran, Arnon P. Kater, Mark-David Levin
Journal: Blood Advances
Blood Adv (2025) 9 (15): 3665–3675.
https://doi.org/10.1182/bloodadvances.2024015180
Published: 2025
Includes: Supplemental data
Journal Articles

One for the ages

Open Access
Christian Brieghel, Emelie Curovic Rotbain, Jelena Jelicic, Sigrún Thorsteinsdóttir, Peter de Nully Brown, Carsten Utoft Niemann
Journal: Blood Advances
Blood Adv bloodadvances.2025016534.
https://doi.org/10.1182/bloodadvances.2025016534
Published: 2025
Includes: Supplemental data
Journal Articles

Incidence and characterization of secondary CNS lymphoma in 1972 patients with DLBCL: a Danish nationwide cohort study

Open Access
Clinical Trials & Observations
Elisabeth Reuben Tolley, Torsten Holm Nielsen, Ditte Stampe Hersby, Simon Østergaard, Malin Rasmussen, Michael Roost Clausen, Ahmed Ludvigsen Al-Mashhadi, Karina Moeslund Egeberg, Laura Mors Haunstrup, Christian Brieghel, Carsten Utoft Niemann, Tarec Christoffer El-Galaly, Lars Møller Pedersen
Journal: Blood Advances
Blood Adv (2025) 9 (4): 893–905.
https://doi.org/10.1182/bloodadvances.2024014404
Published: 2025
Includes: Supplemental data
Journal Articles

It is feasible and safe to stop specialized follow-up of asymptomatic lower-risk chronic lymphocytic leukemia

Free
Clinical Trials & Observations
Christian Brieghel, Caspar da Cunha-Bang, Jindrich Mourek, Lars Kjeldsen, Carsten U. Niemann
Journal: Blood Advances
Blood Adv (2024) 8 (16): 4449–4456.
https://doi.org/10.1182/bloodadvances.2023012382
Published: 2024
Includes: Supplemental data
Journal Articles

CLL-IPI applied in Binet A CLL: a nationwide cohort study

Free
Emelie C. Rotbain, Caspar da Cunha-Bang, Christian Brieghel, Carsten U. Niemann
Journal: Blood Advances
Blood Adv (2022) 6 (21): 5698–5701.
https://doi.org/10.1182/bloodadvances.2021006259
Published: 2022
Includes: Supplemental data
Journal Articles

Prediction of clinical outcome in CLL based on recurrent gene mutations, CLL-IPI variables, and (para)clinical data

Free
Mehdi Parviz, Christian Brieghel, Rudi Agius, Carsten U. Niemann
Journal: Blood Advances
Blood Adv (2022) 6 (12): 3716–3728.
https://doi.org/10.1182/bloodadvances.2021006351
Published: 2022
Includes: Supplemental data